Prostate Cancer Reports

Volume 1 Number 11
 November 2013

Home > Prostate Cancer Reports > Volume 1 - Year 2013 Number 11, November 2013


Localized PCa
Advanced PCa


Etiology and pathogenesis

Ventura S, Evans BA.
Does the autonomic nervous system contribute to the initiation and progression of prostate cancer?
Asian J Androl. 2013 Nov;15(6):715-6. doi: 10.1038/aja.2013.114. Epub 2013 Oct 21.
Abstract | Full text | Related citations

Functional outcomes

Harden J, Sanda MG, Wei JT, Yarandi HN, Hembroff L, Hardy J, Northouse L.
Survivorship after prostate cancer treatment: spouses' quality of life at 36 months.
Oncol Nurs Forum. 2013 Nov;40(6):567-73. doi: 10.1188/13.ONF.567-573.
Abstract | Full text | Related citations

Integrative medicine

Garcia M, Velez R, Romagosa C, Majem B, Pedrola N, Rigau M, Guiu M, Gomis RR, Morote J, Reventós J, Doll A.
Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice.
BJU Int. 2013 Oct 15. doi: 10.1111/bju.12503. [Epub ahead of print]
Abstract | Related citations



Tefekli A, Tunc M.
Future prospects in the diagnosis and management of localized prostate cancer.
ScientificWorldJournal. 2013 Sep 14;2013:347263. doi: 10.1155/2013/347263.
Abstract | Full text | Related citations

Etiology and pathogenesis

Nelson WG, Demarzo AM, Yegnasubramanian S.
The diet as a cause of human prostate cancer.
Cancer Treat Res. 2014;159:51-68. doi: 10.1007/978-3-642-38007-5_4.
Abstract | Related citations

Ricci E, Mattei E, Dumontet C, Eaton CL, Hamdy F, van der Pluije G, Cecchini M, Thalmann G, Clezardin P, Colombel M.
Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression.
Prostate. 2013 Dec;73(16):1738-46. doi: 10.1002/pros.22689. Epub 2013 Sep 21.
Abstract | Related citations

Functional outcomes

Cormie P, Newton RU, Taaffe DR, Spry N, Galvão DA.
Exercise therapy for sexual dysfunction after prostate cancer.
Nat Rev Urol. 2013 Dec;10(12):731-6. doi: 10.1038/nrurol.2013.206. Epub 2013 Oct 8.
Abstract | Related citations


Ross AE, Feng FY, Ghadessi M, Erho N, Crisan A, Buerki C, Sundi D, Mitra AP, Vergara IA, Thompson DJ, Triche TJ, Davicioni E, Bergstralh EJ, Jenkins RB, Karnes RJ, Schaeffer EM.
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy.
Prostate Cancer Prostatic Dis. 2013 Oct 22. doi: 10.1038/pcan.2013.49. [Epub ahead of print]
Abstract | Full text | Related citations

Tanaka A, Ohori M, Paul L, Yu C, Kattan MW, Ohno Y, Tachibana M.
External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy.
Jpn J Clin Oncol. 2013 Dec;43(12):1255-60. doi: 10.1093/jjco/hyt154. Epub 2013 Oct 21.
Abstract | Related citations

Oncologic outcomes

Algarra R, Zudaire J, Tienza A, Velis JM, Merino I, Barba J, Tolosa E, Rincón A, Robles JE, Pascual I.
Radical prostatectomy. Prognostic value of positive surgical margins in pT2 patients.
Arch Esp Urol. 2013 Oct;66(8):796-806. English, Spanish.
Abstract | Related citations

Evans SM, Millar JL, Frydenberg M, Murphy DG, Davis ID, Spelman T, Bolton DM, Giles GG, Dean J, Costello AJ, Frauman AG, Kearns PA, Day L, Daniels C, McNeil JJ.
Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry.
BJU Int. 2013 Oct 15. doi: 10.1111/bju.12509. [Epub ahead of print]
Abstract | Related citations

Molina Escudero R, Herranz Amo F, Páez Borda A, Hernández Fernández C.
Post-radical prostatectomy predictive factors for biochemical recurrence.
Arch Esp Urol. 2013 Oct;66(8):807-14. English, Spanish.
Abstract | Related citations

Paller CJ, Olatoye D, Xie S, Zhou X, Denmeade SR, Eisenberger MA, Antonarakis ES, Carducci MA, Rosner GL.
The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer.
Prostate Cancer Prostatic Dis. 2013 Oct 8. doi: 10.1038/pcan.2013.40. [Epub ahead of print]
Abstract | Full text | Related citations

Røder MA, Thomsen FB, Berg KD, Christensen IJ, Brasso K, Vainer B, Iversen P.
Risk of biochemical recurrence and positive surgical margins in patients with pT2 prostate cancer undergoing radical prostatectomy.
J Surg Oncol. 2013 Oct 24. doi: 10.1002/jso.23469. [Epub ahead of print]
Abstract | Related citations


Atan A, Tuncel A, Yesil S, Balbay D.
Serum testosterone level, testosterone replacement treatment, and prostate cancer.
Adv Urol. 2013;2013:275945. doi: 10.1155/2013/275945. Epub 2013 Sep 18.
Abstract | Full text | Related citations

Treatment comparison

Cozzi G, Lorenzis ED, Palumbo C, Acquati P, Albo G, Dell'orto P, Grasso A, Rocco B.
Robotic prostatectomy: an update on functional and oncologic outcomes.
Ecancermedicalscience. 2013 Sep 26;7:355.
Abstract | Full text | Related citations

Treatment complications

Gay HA, Michalski JM, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal C, Litwin M, Kuban D, Hembroff L, Chang P, Sanda MG; PROSTQA Consortium.
Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study.
Urology. 2013 Dec;82(6):1363-9. doi: 10.1016/j.urology.2013.06.062. Epub 2013 Oct 16.
Abstract | Related citations


Cancer complications

Rizzoli R, Body JJ, Brandi ML, Cannata-Andia J, Chappard D, El Maghraoui A, Glüer CC, Kendler D, Napoli N, Papaioannou A, Pierroz DD, Rahme M, Van Poznak CH, de Villiers TJ, El Hajj Fuleihan G; International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease.
Cancer-associated bone disease.
Osteoporos Int. 2013 Dec;24(12):2929-53. doi: 10.1007/s00198-013-2530-3. Epub 2013 Oct 22.
Abstract | Full text | Related citations

Oncologic outcomes

Rodríguez-Antolín A, Gómez-Veiga F, Alvarez-Osorio JK, Carballido-Rodriguez J, Palou-Redorta J, Solsona-Narbón E, Sánchez-Sánchez E, Unda M.
Factors that predict the development of bone metastases due to prostate cancer: Recommendations for follow-up and therapeutic options.
Actas Urol Esp. 2013 Oct 21. pii: S0210-4806(13)00328-8. doi: 10.1016/j.acuro.2013.09.002. [Epub ahead of print]
Abstract | Related citations